Genital human papillomavirus screening by gene chip in Chinese women of Guangdong province

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 48, Issue 2, 2008, Pages 189-194

  Lin, Min ^a   Yang, Li Ye ^a   Li, Lie Jun ^b   Wu, Jiao Ren ^a   Peng, You Peng ^a   Luo, Zhao Yun ^a  

^a Chaozhou Central Hospital Affiliated to Southern Medical University   (China)

^b Chaozhou Hybribio Limited Corporation   (China)

Author keywords

Cervical cancer screening; Cytology; Gene chip; HPV genotype

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS INFECTION; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA; CHINA; FEMALE; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL NEOPLASMS;

EID: 41149176445     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2008.00844.x     Document Type: Article

References (26)

1. Kjaer SK, van den Brule AJ, Bock JE et al. Human papillomavirus - The most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996 65 : 601 606.
2. Schiffman MH, Bauer HM, Hoover RN et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993 85 : 958 964.
3. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995 87 : 796 802.
4. Speich N, Schmitt C, Bollmann R et al. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: Genotype spectrum of patients from the west German area. J Med Microbiol 2004 53 : 125 128.
5. Xiong XY, Qiu YX, Lin X. Clinic significance of combination of human papillomavirus DNA test and ThinPrep liquid based cytology in diagnosis of early cervical cancer and precancer lesions. Chin J Clin Obstet Gynecol 2006 12 : 97 99.
6. Moreira MA, Longato-Filho A, Taromaru E et al. Investigation of human papillomavirus by hybrid capture II in cervical carcinomas including 113 adenocarcinomas and related lesions. Int J Gynecol Cancer 2006 16 : 586 590.
7. Huang SL, Chao A, Hsueh S et al. Comparison between the Hybrid Capture II Test and an SPF1/GP6+ CPR-based assay for detection of human papillomavirus DNA in cervical swab samples. J Clin Microbiol 2006 44 : 1733 1739.
8. Schiffman M, Herrero R, Desalle R et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005 337 : 76 84.
9. Klintschar M, Neuhuber F. Evaluation of an alkaline lysis method for the extraction of DNA from whole blood and forensic stains for STR analysis. J Forensic Sci 2000 45 : 669 673.
10. Gravitt PE, Peyton CL, Alessi TQ et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000 38 : 357 361.
11. The 1988 Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. Developed and approved at a National Cancer Institute Workshop, Bethesda, Maryland, USA, December 12-13, 1988. J Reprod Med 1989 34 : 779 785.
12. Bernard HU, Chan SY, Manos MM et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994 170 : 1077 1085.
13. Carvalho MO, Almeida RW, Leite FM et al. Detection of human papillomavirus DNA by the hybrid capture assay. Braz J Infect Dis 2003 7 : 121 125.
14. Lin H, Ma YY, Moh JS et al. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 2006 101 : 40 45.
15. Molano M, Posso H, Weiderpass E et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002 87 : 324 333.
16. Rolon PA, Smith JS, Munoz N et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000 85 : 486 491.
17. Bauer HM, Ting Y, Greer CE et al. Genital human papillomavirus infection in female University students as determined by a PCR-based method. JAMA 1991 265 : 472 477.
18. Inoue M, Sakaguchi J, Sasagawa T, Tango M. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. Int J Gynecol Cancer 2006 16 : 1007 1013.
19. He GR, Wu XC. Analysis of the genotyping human papillomavirus from Shenzhen women. J Modern Lab Med 2007 02 : 24 26.
20. Castle PE, Schiffman M, Herrero R. et al. PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2005 14 : 256 260.
21. Koutsky LA, Ault KA, Wheeler CM et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002 347 : 1645 1651.
22. Breitburd F, Coursaget P. Human papillomavirus vaccines. Semin Cancer Biol 1999 9 : 431 444.
23. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 527.
24. Paavonen J, Jenkins D, Bosch FX et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007 369 : 2161 2170.
25. Rozendaal L, Westerga J, van der Linden JC et al. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol 2000 53 : 606 611.
26. Sodhani P, Gupta S, Sharma JK et al. Test characteristics of various screening modalities for cervical cancer: A feasibility study to develop an alternative strategy for resource-limited settings. Cytopathology 2006 17 : 348 352.